/
/
/

Genpharmasec Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Mar 2023
₹50 Cr₹55 Cr₹40 Cr₹33 Cr₹12 Cr₹14 Cr₹8 Cr₹6 Cr₹5 Cr₹10 Cr₹6 Cr₹8 Cr₹6 Cr
₹37 L₹1 Cr₹98 L₹47 L₹70 L₹94 L₹81 L₹75 L₹57 L₹31 L₹14 L₹15 L₹6 L
₹50 Cr₹56 Cr₹41 Cr₹33 Cr₹13 Cr₹15 Cr₹9 Cr₹7 Cr₹6 Cr₹11 Cr₹7 Cr₹8 Cr₹6 Cr
₹49 Cr₹54 Cr₹42 Cr₹34 Cr₹11 Cr₹15 Cr₹8 Cr₹6 Cr₹5 Cr₹10 Cr₹6 Cr₹8 Cr₹6 Cr
₹1 Cr₹3 Cr-₹26 L-₹80,000₹2 Cr-₹8 L₹2 Cr₹87 L₹75 L₹30 L₹16 L₹11 L₹27 L
₹40 L₹48 L₹41 L₹23 L₹12 L₹11 L₹16 L₹7 L₹10 L₹16 L₹50,000₹7 L₹6 L
₹26 L₹2 Cr-₹1 Cr-₹80 L₹1 Cr-₹44 L₹1 Cr₹50 L₹49 L₹11 L₹3 L₹4 L₹20 L
-₹17 L₹1 Cr-₹83 L-₹1 Cr₹1 Cr-₹28 L₹76 L₹70 L₹29 L₹49 L₹6 L₹60,000₹1 Cr

Share Price Live Stats

Open (₹)1.26
Volume (₹)11.91 L
High (₹)1.33
Upper Circuit1.48
Low (₹)1.23
Lower Circuit1.00
Prev Close1.24
52W High (₹)2.15
Price1.26
52W Low (₹)0.75

Share Market Cap & Key Ratios Overview

M.Cap (₹)68.66 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.05
Price to Book1.61
Book Value1.18
EPS (TTM)-0.00
Face Value1.00
ROE (%)1.90

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
ADANIENT-ANSE
PREMIERENE-ANSE
AEGISLOG-ANSE
CPPLUS-ANSE
REDINGTON-ANSE
HONASA-ANSE
LLOYDSENT-ANSE
CELLO-ANSE
JSLL-ANSE
BLACKROSE-TNSE
GENPHARMA-XNSE
LTP
1W Low
1W High
Market cap (₹)
2936-230 (-7.26%)
2831.65
3168
3,90,684Cr
998-16 (-1.58%)
995.50
1028.55
45,486Cr
1267-22.6 (-1.75%)
1180.45
1327.30
45,144Cr
3722.05+145.1 (4.06%)
3458.85
3796.35
44,346Cr
371.6+5.75 (1.57%)
343.80
378.95
29,113Cr
476.5+5.75 (1.22%)
465.25
494
15,566Cr
74+0.86 (1.18%)
69.53
74.50
10,984Cr
342.6-8.4 (-2.39%)
340.10
357.45
7,747Cr
518.95+7 (1.37%)
497.75
529.80
6,238Cr
114.2-0.8 (-0.70%)
110.60
116.95
572Cr
1.26+0.23 (22.33%)
1.02
1.36
69Cr

Key Highlights of Genpharmasec Ltd’s P&L

In 2025-03-31, Genpharmasec Ltd reported total revenue of ₹36.78Cr, compared with ₹31.06Cr in 2024-03-31, reflecting Genpharmasec Ltd turnover.

Depreciation was ₹81.15Lakh and finance costs were ₹44.78Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹1.88Cr in 2025-03-31 as compared to ₹25.06Lakh in 2024-03-31.

Net Profit (PAT) was ₹1.25Cr in 2025-03-31 compared with ₹-₹12.57Lakh in 2024-03-31.

Earnings per share (EPS) were ₹0.02 in 2025-03-31, compared with ₹0 in 2024-03-31.